Guided Therapeutics, Inc. (GTHP)
OTCMKTS · Delayed Price · Currency is USD
0.2500
-0.0200 (-7.41%)
Nov 6, 2025, 3:42 PM EST
Guided Therapeutics Revenue
Guided Therapeutics had revenue of $117.00K in the quarter ending June 30, 2025. This brings the company's revenue in the last twelve months to $118.00K, up 210.53% year-over-year. In the year 2024, Guided Therapeutics had annual revenue of $7.00K, down -92.86%.
Revenue (ttm)
118.00K
Revenue Growth
+210.53%
P/S Ratio
191.29
Revenue / Employee
29.50K
Employees
4
Market Cap
22.57M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 7.00K | -91.00K | -92.86% |
| Dec 31, 2023 | 98.00K | 85.00K | 653.85% |
| Dec 31, 2022 | 13.00K | -68.00K | -83.95% |
| Dec 31, 2021 | 81.00K | -21.00K | -20.59% |
| Dec 31, 2020 | 102.00K | 66.00K | 183.33% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| American Oncology Network | 1.76B |
| Veradigm | 588.02M |
| Jushi Holdings | 256.36M |
| Glass House Brands | 221.55M |
| Chrome Holding Co. | 174.90M |
| Elite Pharmaceuticals | 105.45M |
| Silence Therapeutics | 27.17M |
| Nuo Therapeutics | 2.61M |
Guided Therapeutics News
- 2 months ago - Guided Therapeutics Receives $70,000 -- Its Second of Nine Payments Totaling $700,000 -- from New Chinese Distribution Partner that Provides Products for 2 Million Annual Cervical Cancer Screenings - Business Wire
- 3 months ago - Guided Therapeutics Provides Update on Completion of US FDA Clinical Trial - Business Wire
- 4 months ago - Guided Therapeutics Makes Initial Shipment to New Chinese Distribution Partner Hangzhou Dongye Medical Technology, Ltd. - Business Wire
- 5 months ago - Guided Therapeutics Receives $700,000 Purchase Order and Initial Payment from New Chinese Distributor - Business Wire
- 5 months ago - Guided Therapeutics Receives $100,000 from SMI's Investment Partners to Continue Commercialization Process of LuViva in China - Business Wire
- 11 months ago - Guided Therapeutics Receives Order and Full Payment From Indonesia for 4 LuViva Systems and 1,200 Disposables - Business Wire
- 1 year ago - Guided Therapeutics' Announces Data from Chinese NMPA Clinical Study Signed Off by All Four Clinical Sites With Better Than Expected Results - Business Wire
- 1 year ago - Leading Cervical Cancer Doctors Support Approval of LuViva in China Based on Preliminary Review of Clinical Trial Results - Business Wire